Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: At diagnosis and following treatment

Journal of Internal Medicine

Volumn 239, Issue 1, 1996, Pages 63-68

  Hallengren, B ^a   Falorni, A ^b   Landin Olsson, M ^a   Lernmark, A ^b   Papadopoulos, K I ^a   Sundkvist, G ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glutamic acid decarboxylase antibodies; Gravest disease; Hyperthyroidism; Insulin dependent diabetes mellitus; Islet cell antibodies; Radio iodine

Indexed keywords

ANTITHYROID AGENT; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; PRIORITY JOURNAL; SWEDEN; THYROID ADENOMA;

EID: 0030049844     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.417758000.x     Document Type: Article

References (26)

1. Cooppan R, Kozak GP. Hyperthyroidism and diabetes mellitus. Arch Intern Med 1980; 140: 370-3.
2. Gray RS, Herd R, Clarke BF. The clinical features of diabetes with coexisting autoimmune thyroid disease. Diabetologia 1981; 20: 602-6.
3. Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G. The diabetes incidence study in Sweden group. Islet cell and thyrogastric antibodies in 633 consecutive 15-34-year-old patients in the diabetes incidence study in Sweden. Diabetes 1992; 41: 1022-7.
4. Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark Å, Baekkeskov S. Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31: 597-602.
5. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T et al. Antibodies to a 64000 M, human islet cell antigen precede the clinical onset of insulin dependent diabetes. J Clin Invest 1987; 79: 926-34.
6. Kawasaki E, Takino H, Yano M, Uoatani S, Matsumoto K, Takao Y et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43: 80-6.
7. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-26.
8. Irvine WJ, McCallum CJ, Gray RS, Cambell CJ, Duncan LJP, Farquhar JW et al. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 1977; 26: 138-47.
9. Hallengren B. Landin-Olsson M, Lernmark Å, Sundkvist G. Islet cell antibodies in patients with Graves' disease in relation to antithyroid drug treatment (Abstract). Annales d'endocrinologie 1989; 50: 101.
10. 1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose evaluated. Clin Chem. 1986; 32: 1867-72.
11. Landin-Olsson M, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titers of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-32.
12. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387-95.
13. Clauson P, Linnarsson R, Gottsäter A, Sundkvist G, Grill V. Relationships between diabetes duration, metabolic control and beta cell function in a representative population of Type 2 diabetic patients in Sweden. Diabet Med 1994; 11: 794-801.
14. Grubin CK, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-50.
15. Gottsäter A, Landin-Olsson M, Fernlund P, Gullberg B, Lernmark Å, Sundkvist G. Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion. Scand J Clin Lab Invest 1992; 52: 631-9.
16. Hallengren B, Forsgren A, Melander A. Effects of antithyroid drugs on luymphocyte function in vitro. J. Clin Endocrinol Metab 1980; 51: 298-301.
17. Yamaguchi Y, Chikuba N, Ueda Y, Yamamoto U, Yamasaki H, Nakanishi T et al. Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 1991; 40: 319-22.
18. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF et al. Predicting insulin-dependent diabetes. Lancet 1988; i: 845-50.
19. Vandewalle CL, Falorni A, Svanholm S, Lernmark Å, Pipeleers DG, Gorus FK, and Belgian Diabetes registry. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995; 80: 846-51.
20. Karlsen AE, Hagopian WA,. Grubin CE, Dube S, Disteche CM, Adler DA et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 1991; 88: 8337-41.
21. Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moddy A, Grubin CE et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-5.
22. Christie MR, Brown TJ, Cassidy D. Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues: evidence for antigenie and non-antigenic forms of the enzyme. Diabetologia 1992; 35: 380-4.
23. Andersson DKG, Svärdsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabet Med 1991; 8: 428-34.
24. Marner B, Agner T, Binder C, Lernmark Å, Nerup J, Mandrup-Poulsen T et al. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients. Diabetologia 1985; 28: 875-80.
25. Lamberg B-A. Glucose metabolism in thyroid disease. Acta Med Scand 1965; 178: 351-62.
26. Ahrén B, Lundquist I, Hedner P, Valdemarsson S, Scherstén B. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment. Diabetes Res 1985; 2: 95-103.